Status:
COMPLETED
Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™
Lead Sponsor:
International Vaccine Institute
Collaborating Sponsors:
EuBiologics Co.,Ltd
Conditions:
Cholera
Eligibility:
All Genders
1-40 years
Phase:
PHASE3
Brief Summary
This study is to evaluate immune non-inferiority, safety and lot-to-lot consistency of OCV-S compared to Shanchol™ in 1 to 40 years old healthy Nepalese participants. The investigators hypothesize tha...
Eligibility Criteria
Inclusion
- Healthy participants 1 to 40 years of age at enrollment
- Participants/Parent(s)/Legally authorized representative (LAR) willing to provide written informed consent to participate study voluntarily
- Participants/Parent(s)/LAR who can be followed up during the study period and can comply with the study requirements
Exclusion
- Known history of hypersensitivity reactions to other preventive vaccines
- Severe chronic diseases or medical conditions based on the medical judgment of the investigator. In particular, a participant with a) chronic infection such as tuberculosis, or sequel of poliomyelitis, b) known history of immune function disorders, c) chronic use of systemic steroids (\>2 mg/kg/day or \>20 mg/day prednisone equivalent for periods exceeding 10 days)/cytotoxic drugs/immunosuppressants within past 6 weeks, d) active malignancy with the exception of adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated Stage I cancer from which the participant is currently in complete remission, or any other cancer from which the participant has been disease-free for 5 years, e) Congestive heart failure, f) myocardial infarction within the previous 6 months, g) known HIV-infected patients, h) neurological and/or psychiatric disorder, or i) known history of uncontrolled coagulopathy or blood disorders
- Participant who planned to or has received other vaccines from 1 month prior to test vaccination excluding a public health vaccination campaign due to an outbreak
- Participant concomitantly enrolled or scheduled to be enrolled in another trial
- Receipt of blood or blood-derived products in the past 3 months
- Participant who has previously received a cholera vaccine
- Any female participant who is lactating, pregnant or planning for pregnancy during study period
- Participants planning to move from the study area before the end of study period
- Employees or the family members of the OCV-S study sites
- Temporary Contraindication:
- Should a participant have one of the conditions/situations listed below, the Investigator will postpone primary or subsequent vaccination until the condition/situation is resolved.
- Febrile illness (axillary temperature ≥ 37.5°C) or moderate or severe acute illness/infection on the day of vaccination or planned vaccination, according to Investigator's judgment.
- Gastrointestinal symptoms including nausea, vomiting, or decreased appetite within 24 hours prior to study initiation.
- Administration of antidiarrheal drugs or antibiotics to treat diarrhea or abdominal pain lasting 2 weeks or longer within 6 months prior to study initiation
- Diarrhea occurring up to 1 week within 6 months prior to study initiation.
- Lactation: Breastfeeding women will not be enrolled. Should a female participant decide to breastfeed during the vaccination period, she will be excluded from further vaccination, but will be followed for safety until the end of the study
- Pregnancy Test is necessary for all married female participants of childbearing age.
Key Trial Info
Start Date :
October 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 21 2023
Estimated Enrollment :
2530 Patients enrolled
Trial Details
Trial ID
NCT04760236
Start Date
October 6 2021
End Date
March 21 2023
Last Update
June 22 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Nepalgunj medical college
Bānke, City- Nepalgunj, Nepal
2
B.P.Koirala Institute of Health Sciences
Rautahat, Dharan, Nepal
3
Dhulikhel Hospital
Kavre, Dhulikhel, Nepal
4
Kanti Children's Hospital
Kathmandu, Sukedhara, Nepal, 44600